RetinalGenix Technologies Inc. (RTGN)
- Previous Close
0.00 - Open
3.50 - Bid 3.60 x --
- Ask 5.25 x --
- Day's Range
3.50 - 3.50 - 52 Week Range
0.00 - 6.36 - Volume
451 - Avg. Volume
1 - Market Cap (intraday)
92.982M - Beta (5Y Monthly) -3.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.24 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
retinalgenix.comRecent News: RTGN
View More
Performance Overview: RTGN
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RTGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RTGN
View MoreValuation Measures
Market Cap
92.98M
Enterprise Value
93.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-35,731.92%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.32M
Diluted EPS (ttm)
-0.24
Balance Sheet and Cash Flow
Total Cash (mrq)
6.06k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--